Competing interests
Noriya
Satoki Shichijo has received personal fees from Olympus Corporation, Daiichi-Sankyo, EA Pharma, AstraZeneca, AI Medical Service Inc., and Jannsen Pharmaceutical. Takashi Kanesaka has received personal fees from Olympus Corporation. Yoji Takeuchi has received personal fees from Olympus Corporation, Boston Scientific Japan, FUJIFILM Medical Co., Ltd, Daiichi-Sankyo, Miyarisan Pharmaceutical, Asuka Pharmaceutical, AstraZeneca, EA Pharma, Zeria Pharmaceutical, Fujifilm, Kaneka Medix, and Kyorin Pharmaceutical. Noriya Uedo has received personal fees from Olympus Corporation, Boston Scientific Japan, FUJIFILM Medical Co., Ltd, Daiichi-Sankyo, Takeda Pharmaceutical, EA Pharma, Otsuka Pharmaceutical, AstraZeneca, AI Medical Service Inc., and Miyarisan Pharmaceutical. Ryu Ishihara has received personal fees from Olympus Corporation and FUJIFILM Medical Co., Ltd, Daiichi-Sankyo, Ono Pharmaceutical, EA Pharma, and AstraZeneca. Tomohiro Tada is a shareholder in AI Medical Service Inc. and holds the following patent PCT/JPT2018/040381. The other authors have no financial relationships to disclose.